FREQUENCY THERAPEUTICS
Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Through the transitory activation of these progenitor cells, Frequency enables disease modification without the complexity of genetic engineering. It was founded in 2015 and headquartered in Woburn, Massachusetts.
FREQUENCY THERAPEUTICS
Industry:
Biotechnology Genetics Medical
Founded:
2015-01-01
Address:
Woburn, Massachusetts, United States
Country:
United States
Website Url:
http://www.frequencytx.com
Total Employee:
51+
Status:
Active
Contact:
866-389-1970
Email Addresses:
[email protected]
Total Funding:
76.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins Sitelinks Search Box
Similar Organizations
Entrada Therapeutics
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Taiwania Capital Management Corporation
Taiwania Capital Management Corporation investment in Post-IPO Equity - Frequency Therapeutics
Wasatch Advisors
Wasatch Advisors investment in Post-IPO Equity - Frequency Therapeutics
Driehaus Capital Management
Driehaus Capital Management investment in Post-IPO Equity - Frequency Therapeutics
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Equity - Frequency Therapeutics
Alexandria Venture Investments
Alexandria Venture Investments investment in Post-IPO Equity - Frequency Therapeutics
RTW Investments LLC
RTW Investments LLC investment in Post-IPO Equity - Frequency Therapeutics
Federated Kaufmann Fund
Federated Kaufmann Fund investment in Post-IPO Equity - Frequency Therapeutics
Maven Investment Partners US
Maven Investment Partners US investment in Post-IPO Equity - Frequency Therapeutics
Mizuho Securities Principal Investment
Mizuho Securities Principal Investment investment in Series C - Frequency Therapeutics
Rivas Capital
Rivas Capital investment in Series C - Frequency Therapeutics
Key Employee Changes
Date | New article |
---|---|
2021-01-19 | Frequency Therapeutics Appoints Quentin McCubbin, Ph.D., as Chief Manufacturing Officer |
Official Site Inspections
http://www.frequencytx.com Semrush global rank: 2.54 M Semrush visits lastest month: 6.93 K
- Host name: 104.26.2.12
- IP address: 104.26.2.12
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago